F1TITLE IINTRODUCTORY PROVISIONS
Annotations:
Amendments (Textual)
F1CHAPTER 1Subject matter and definitions
F1Article 1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
F1Article 2
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation revoked (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), Sch. 9 para. 1(l) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)